Kaleido Biosciences reaffirms cash runway into Q1 of 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Marinus Pharmaceuticals loses 80% of its market value in one day after setback for new drug candidate
Marinus Pharmaceuticals said it will implement cost-cutting measures to extend its cash runway beyond the fourth quarter of 2024......»»
Scynexis sees cash runway into 2023
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Galectin expects cash to fund operations at least through Sept. 30, 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Angion Biomedica expects cash to fund planned operations into 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cerevel Therapeutics sees cash runway into 2024
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences expects cash to fund expenditures into 4Q22
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Phathom Pharmaceuticals sees cash, cash equivalents last into Q4 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Piper says ImmunoGen"s "modest" timeline slip makes cash runway "more tenuous"
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fisker reaffirms target for Ocean to start production in Q4 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immutep sees cash runway into calender year 2023
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Albireo Pharma sees cash runway into 2023
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioCryst sees cash runway to take the company into 2023
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Autolus Therapeutics sees cash runway into 1H23
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Epizyme sees current cash runway to extend into 2023
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
EyePoint sees cash able to fund planned operations through end of 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Greif reaffirms fiscal 2022 sales outlook of $5B, consensus $4.95B
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Kaleido Biosciences reports Q1 EPS (58c), consensus (59c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Genocea expects cash to fund operations to the end of 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Interpace Biosciences reaffirms FY21 revenue view $42M-$44M, consensus $39.6M
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Orion Energy reaffirms 2022 revenue view of at least $150M, consensus $161.8M
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»